Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT03233087, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Beijing Institute of Heart, Lung and Blood Vessel Diseases
- Trial code
- NCT03233087
- Record updated
- 27 June 2024
- Original description
The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm/aortic dissection.Read full original descriptionShow less
Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen
The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm/aortic dissection.
Inclusion: Retrospective; All patients who were referred to the surgical service for evaluation and management of aortic dissection were included; Perspective; Patients with initial suspicion of having AAD were perspectively enrolled.
Exclusion: Patients who entered the hospital for checkups after surgery; Perspective; Patients with aortic trauma, pseudo aneurysm, history of heart failure, renal dysfunction, severe pulmonary diseases, or active cancer; Patients in whom there is little or no suspicion of a life-threatening disease; Patients with confirmed acute myocardial infarction,angina or pulmonary embolism; The symptoms were clearly not related to AD (e.g. pleurisy, pneumonia, acute abdominal diseases); Patients who received packed red blood cells, whole blood, or platelets less than 10 days before the blood sample was taken; Retrospective.